Literature DB >> 26617322

Notch in T Cell Differentiation: All Things Considered.

Derk Amsen1, Christina Helbig2, Ronald A Backer3.   

Abstract

Differentiation of naïve T cells into effector cells is required for optimal protection against different classes of microbial pathogen and for the development of immune memory. Recent findings have revealed important roles for the Notch signaling pathway in T cell differentiation into all known effector subsets, raising the question of how this pathway controls such diverse differentiation programs. Studies in preclinical models support the therapeutic potential of manipulating the Notch pathway to alleviate immune pathology, highlighting the importance of understanding the mechanisms through which Notch regulates T cell differentiation and function. We review these findings here, and outline both unifying principles involved in Notch-mediated T cell fate decisions and cell type- and context-specific differences that may present the most suitable points for therapeutic intervention.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2015        PMID: 26617322     DOI: 10.1016/j.it.2015.10.007

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  64 in total

1.  Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells.

Authors:  Pleun Hombrink; Christina Helbig; Ronald A Backer; Berber Piet; Anna E Oja; Regina Stark; Giso Brasser; Aldo Jongejan; René E Jonkers; Benjamin Nota; Onur Basak; Hans C Clevers; Perry D Moerland; Derk Amsen; René A W van Lier
Journal:  Nat Immunol       Date:  2016-10-24       Impact factor: 25.606

2.  T cells take directions from supporting cast in graft-versus-host disease.

Authors:  Derk Amsen
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

3.  Trigger-happy resident memory CD4+ T cells inhabit the human lungs.

Authors:  A E Oja; B Piet; C Helbig; R Stark; D van der Zwan; H Blaauwgeers; E B M Remmerswaal; D Amsen; R E Jonkers; P D Moerland; M A Nolte; R A W van Lier; P Hombrink
Journal:  Mucosal Immunol       Date:  2017-11-15       Impact factor: 7.313

4.  Jagged1-expressing adenovirus-infected dendritic cells induce expansion of Foxp3+ regulatory T cells and alleviate T helper type 2-mediated allergic asthma in mice.

Authors:  Chu-Lun Lin; Huei-Mei Huang; Chia-Ling Hsieh; Chia-Kwung Fan; Yueh-Lun Lee
Journal:  Immunology       Date:  2018-11-29       Impact factor: 7.397

Review 5.  Epigenetic control of the tumor microenvironment.

Authors:  David L Marks; Rachel Lo Olson; Martin E Fernandez-Zapico
Journal:  Epigenomics       Date:  2016-10-04       Impact factor: 4.778

6.  Notch signaling licenses allergic airway inflammation by promoting Th2 cell lymph node egress.

Authors:  Irma Tindemans; Anne van Schoonhoven; Alex KleinJan; Marjolein Jw de Bruijn; Melanie Lukkes; Menno van Nimwegen; Anouk van den Branden; Ingrid M Bergen; Odilia Bj Corneth; Wilfred Fj van IJcken; Ralph Stadhouders; Rudi W Hendriks
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

7.  Novel TCR-Mediated Mechanisms of Notch Activation and Signaling.

Authors:  Martin Peter Steinbuck; Ksenia Arakcheeva; Susan Winandy
Journal:  J Immunol       Date:  2017-12-29       Impact factor: 5.422

8.  Notch1 primes CD4 T cells for T helper type I differentiation through its early effects on miR-29.

Authors:  Karthik Chandiran; Rebecca Lawlor; Antonio Pannuti; Gabriela Gonzalez Perez; Janani Srinivasan; Todd E Golde; Lucio Miele; Barbara A Osborne; Lisa M Minter
Journal:  Mol Immunol       Date:  2018-05-26       Impact factor: 4.407

9.  The microvascular niche instructs T cells in large vessel vasculitis via the VEGF-Jagged1-Notch pathway.

Authors:  Zhenke Wen; Yi Shen; Gerald Berry; Farhad Shahram; Yinyin Li; Ryu Watanabe; Yaping Joyce Liao; Jörg J Goronzy; Cornelia M Weyand
Journal:  Sci Transl Med       Date:  2017-07-19       Impact factor: 17.956

Review 10.  Therapeutic potential of targeting acinar cell reprogramming in pancreatic cancer.

Authors:  Chi-Hin Wong; You-Jia Li; Yang-Chao Chen
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.